Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 144 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Low Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

NCT03625388

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +12 more
Locations
  • King Hussein Cancer Center (KHCC) Amman, Jordan
  • Jordan University Hospital (JUH) Amman, Jordan
  • American University of Beirut Medical Center (AUBMC) Beirut, Lebanon
  • The King Faisal Specialist Hospital and Research Centre (KFSH&RC) Riyadh, Saudi Arabia
View Trial Details
Completed

A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor

NCT01696461

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +31 more
Locations
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated Myelofibrosis Who Have Anemia With and Without Red Blood Cell-transfusion Dependence

NCT03194542

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +3 more
Locations
  • Local Institution - 102 Phoenix, Arizona, United States
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • Local Institution - 103 Stanford, California, United States
  • Stanford Cancer Center Stanford, California, United States
View all 47 locations
View Trial Details
Completed

Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent Line

NCT05734053

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Novartis Investigative Site Freudenstadt, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Aschaffenburg, Bavaria, Germany
  • Novartis Investigative Site Augsburg, Bavaria, Germany
  • Novartis Investigative Site Bayreuth, Bavaria, Germany
View all 77 locations
View Trial Details

Related conditions